Reports for AA PHARMA INC
Company Name AA PHARMA INC |
||
|---|---|---|
Totals |
||
Shortage reports |
446 |
|
| Actual shortage: | 21 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (1%) | |
| Resolved: | 419 (94%) | |
Discontinuation Reports |
63 |
|
| To be discontinued: | 9 (14%) | |
| Discontinued: | 52 (83%) | |
| Reversed: | 2 (3%) | |
Late reports |
30 (6%) |
|
Overdue reports |
20 (67%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENO-MICRO | 200MG | CAPSULE | Resolved | 2017-11-28 | 2018-07-17 | 30995 |
| APO-FENO-MICRO | 200MG | CAPSULE | Resolved | 2017-07-26 | 2017-10-05 | 17228 |
| APO-FENO-MICRO | 200MG | CAPSULE | Resolved | 2017-04-07 | 2017-05-26 | 5894 |
| APO-FENO-MICRO | 200MG | CAPSULE | Resolved | 2017-03-21 | 2017-06-05 | 3749 |
| APO-FENO-MICRO | 200MG | CAPSULE | Resolved | 2017-03-14 | 2017-05-12 | 2295 |
| APO-FENO-SUPER | 100MG | TABLET | Resolved | 2017-03-10 | 2019-11-26 | 321 |
| APO-FENO-SUPER | 100MG | TABLET | Resolved | 2017-04-12 | 2017-04-28 | 6551 |
| APO-FENO-SUPER | 100MG | TABLET | Resolved | 2017-07-11 | 2019-05-25 | 15268 |
| APO-FENO-SUPER | 100MG | TABLET | Resolved | 2021-06-25 | 2022-02-23 | 141529 |
| APO-FENO-SUPER | 100MG | TABLET | Resolved | 2021-09-09 | 2021-09-24 | 145407 |
| APO-FENO-SUPER | 160MG | TABLET | Resolved | 2017-03-20 | 2018-05-15 | 3524 |
| APO-FENO-SUPER | 160MG | TABLET | Resolved | 2017-05-02 | 2017-08-29 | 8593 |
| APO-FENO-SUPER | 160MG | TABLET | Resolved | 2018-05-15 | 2018-08-27 | 49362 |
| APO-FENO-SUPER | 160MG | TABLET | Resolved | 2019-05-08 | 2019-08-19 | 83502 |
| APO-FENO-SUPER | 160MG | TABLET | Resolved | 2021-01-22 | 2021-01-26 | 132352 |
| APO-FENO-SUPER | 160MG | TABLET | Resolved | 2021-09-15 | 2021-09-24 | 145663 |
| APO-FENOFIBRATE | 100 MG | CAPSULE | Resolved | 2017-03-11 | 2019-11-26 | 622 |
| APO-FLURBIPROFEN FC TABLETS 100MG | 100MG | TABLET | Resolved | 2017-11-28 | 2018-09-07 | 30928 |
| APO-IPRAVENT SOLUTION - INH 250MCG/ML | 250µG | SOLUTION | Resolved | 2017-03-11 | 2017-04-11 | 613 |
| APO-IPRAVENT SOLUTION - INH 250MCG/ML | 250MCG | SOLUTION | Resolved | 2019-04-04 | 2019-07-02 | 80536 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PHENYTOIN SODIUM | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-12-28 | 60687 |
| AVENTYL | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65435 |
| CHLORAX | 2.5MG 5MG | CAPSULE | Discontinued | 2022-01-20 | 2022-01-21 | 153244 |
| CHLORDIAZEPOXIDE | 10MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231340 |
| CHLORDIAZEPOXIDE | 5MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231343 |
| CHLORDIAZEPOXIDE | 25MG | CAPSULE | To be discontinued | 2024-06-26 | 2024-06-26 | 231348 |
| DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
| DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
| DOXEPIN | 50MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65463 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247839 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247836 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247833 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247830 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247827 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247824 |
| ELAVIL | 75MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247842 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2022-04-01 | 2022-04-02 | 157808 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4584 |
| ERYTHRO-ES | Discontinued | 2018-12-07 | 2018-12-08 | 68904 | ||
| ERYTHRO-ES | 600MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121825 |